drugset
Drugs / Mesenchymal stem cells (MSC)
last change Dec 2022 re-read 3 minutes ago

Mesenchymal stem cells (MSC)

Cell therapy

Developed for
lupus nephritis
Investigated by
Citospin · Hospital Clínico Universitario de Valladolid · Hospital del Rio Hortega · Red de Terapia Celular · University of Valladolid

Trials 1

today NCT03673748 · Ph 2
20232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03673748 Dec 2022 → Dec 2026 expected lupus erythematosus, lupus nephritis Red de Terapia Celular Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mesenchymal stem cells (MSC) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03673748 ↗
Modality Cell therapy “mesenchymal stem cells (MSCs) obtained from bone marrow” NCT03673748 ↗
Route Intravenous “by intravenous injection” NCT03673748 ↗